Kewalramani Reshma — SEC insider filings
SEC reporting owner CIK 1735944. 52 insider filings on record with FilingPulse; latest filed 2026-11-10.
Transaction summary — filings shown
Covers the 50 most recent of 52 filings on record, filed 2021-02-12 to 2026-11-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 2 filings — 20,000 shares, $5,852,259 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 29 legs across 15 filings — 186,088 shares, $81,560,301 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 54.
- Largest priced transaction: sale of 15,198 shares @ $515.00 ($7,826,970) in VERTEX PHARMACEUTICALS INC / MA, filed 2024-11-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | CEO & President, Director | 44 | 4 legs · 20,000 sh · $5,852,259 | 29 legs · 186,088 sh · $81,560,301 | 43 |
| Ginkgo Bioworks Holdings, Inc. (DNA) | Director | 6 | — | — | 11 |
Insider filings — Kewalramani Reshma
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-10 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 11,866 @ $531.53 | EDGAR |
| 2026-03-03 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 400 @ $479.75 · Sale (S): 120 @ $481.50 · Sale (S): 240 @ $482.84 · Sale (S): 2,510 @ $487.13 · Sale (S): 3,278 @ $488.27 · Sale (S): 460 @ $489.32 · +7 more | EDGAR |
| 2026-02-26 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 4,981 @ $485.11 | EDGAR |
| 2026-02-19 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 16,326 @ $0 · Tax withholding (F): 6,554 @ $483.75 | EDGAR |
| 2026-02-18 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 13,041 @ $487.76 | EDGAR |
| 2026-02-12 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 8,297 @ $468.41 | EDGAR |
| 2026-01-26 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 26,972 @ $0 · Grant/award (A): 11,885 @ $0 | EDGAR |
| 2025-08-07 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Purchase (P): 4,290 @ $389.08 · Purchase (P): 5,710 @ $389.95 | EDGAR |
| 2025-02-28 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 14,079 @ $479.61 | EDGAR |
| 2025-02-26 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 9,386 @ $483.28 | EDGAR |
| 2025-02-19 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 6,553 @ $463.46 | EDGAR |
| 2025-02-14 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 19,015 @ $0 | EDGAR |
| 2025-02-12 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 8,300 @ $467.98 | EDGAR |
| 2025-02-06 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 29,118 @ $0 · Grant/award (A): 20,328 @ $0 | EDGAR |
| 2024-11-12 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 15,198 @ $515 | EDGAR |
| 2024-08-01 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 15,202 @ $505 | EDGAR |
| 2024-07-24 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 15,202 @ $497 | EDGAR |
| 2024-06-14 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Option exercise (M): 105,263 · Option exercise (M): 105,263 (derivative) | EDGAR |
| 2024-05-29 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Option exercise (M): 1,565 @ $187.53 · Sale (S): 1,565 @ $457 · Option exercise (M): 1,565 (derivative) @ $0 | EDGAR |
| 2024-05-22 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 15,202 @ $447 | EDGAR |
| 2024-02-27 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 9,386 @ $431.79 | EDGAR |
| 2024-02-21 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 9,359 @ $424.01 · Tax withholding (F): 7,019 @ $420.58 | EDGAR |
| 2024-02-13 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 8,255 @ $422.74 | EDGAR |
| 2024-02-08 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 14,516 @ $0 · Grant/award (A): 26,972 @ $0 · Grant/award (A): 20,327 @ $0 | EDGAR |
| 2023-12-19 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Option exercise (M): 3,058 @ $155.57 · Option exercise (M): 14,077 @ $187.53 · Sale (S): 17,135 @ $407 · Option exercise (M): 3,058 (derivative) @ $0 · Option exercise (M): 14,077 (derivative) @ $0 | EDGAR |
| 2023-12-15 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 5,098 @ $397 | EDGAR |
| 2023-11-15 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 5,097 @ $377 | EDGAR |
| 2023-07-18 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 7,828 @ $355 | EDGAR |
| 2023-06-21 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Grant/award (A): 105,263 (derivative) @ $0 · Grant/award (A): 139,860 (derivative) @ $0 | EDGAR |
| 2023-05-01 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 1,611 @ $338.69 · Sale (S): 1,668 @ $339.43 · Sale (S): 38 @ $340.19 | EDGAR |
| 2023-02-28 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 9,386 @ $289.12 | EDGAR |
| 2023-02-22 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 9,359 @ $292.85 | EDGAR |
| 2023-02-14 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 3,372 @ $294.33 · Tax withholding (F): 5,990 @ $298.26 | EDGAR |
| 2023-02-03 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 12,388 @ $0 · Grant/award (A): 29,118 @ $0 · Grant/award (A): 26,972 @ $0 | EDGAR |
| 2023-01-27 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 10,000 @ $315.05 | EDGAR |
| 2022-11-10 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Option exercise (M): 9,818 · Option exercise (M): 9,818 (derivative) @ $0 | EDGAR |
| 2022-08-17 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 11,689 @ $305.06 | EDGAR |
| 2022-07-21 | 4/A | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Holdings only — no transactions reported | EDGAR |
| 2022-06-28 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 11,689 @ $291.30 | EDGAR |
| 2022-06-13 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Grant/award (A): 70,921 @ $0 · Grant/award (A): 108,516 (derivative) @ $0 | EDGAR |
| 2022-02-28 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 7,246 @ $227.86 | EDGAR |
| 2022-02-22 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 8,584 @ $232.51 | EDGAR |
| 2022-02-14 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 3,031 @ $237.74 | EDGAR |
| 2022-02-03 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 9,800 @ $0 · Grant/award (A): 29,032 @ $0 · Grant/award (A): 29,117 @ $0 | EDGAR |
| 2021-11-23 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Grant/award (A): 9,818 (derivative) @ $0 | EDGAR |
| 2021-09-20 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Grant/award (A): 51,782 (derivative) @ $0 · Grant/award (A): 17,649 (derivative) @ $0 | EDGAR |
| 2021-08-23 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Purchase (P): 5,757 @ $195.14 · Purchase (P): 4,243 @ $196.34 | EDGAR |
| 2021-02-26 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 2,898 @ $217.57 | EDGAR |
| 2021-02-19 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 2,080 @ $211.75 | EDGAR |
| 2021-02-12 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 2,962 @ $214.16 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1735944 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs